<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04259008</url>
  </required_header>
  <id_info>
    <org_study_id>2001902</org_study_id>
    <nct_id>NCT04259008</nct_id>
  </id_info>
  <brief_title>Safety of Manganese Restriction in Neonatal Parenteral Nutrition</brief_title>
  <official_title>Safety of Manganese Restriction in Neonatal Parenteral Nutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sharp HealthCare</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Food and Drug Administration (FDA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Sharp HealthCare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants will be &lt;= 32 weeks gestational age (GA) neonates randomized to parenteral&#xD;
      nutrition (PN) prepared with standard dose trace elements or to PN prepared with standard&#xD;
      trace elements minus manganese.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Very preterm neonates &lt;= 32+6 weeks GA receiving PN will be randomized to receive their PN&#xD;
      prepared with standard trace elements containing 5 mcg/kg/day of manganese, or to PN prepared&#xD;
      with no added manganese. Randomization assignment will be double masked. All participants&#xD;
      will have whole blood manganese measurements at baseline, at 2 weeks of postnatal age, and at&#xD;
      8 weeks postnatal age. Because manganese is present as a contaminant in many of the&#xD;
      ingredients used to prepare neonatal PN, this study hypothesizes that neonates randomized to&#xD;
      no added manganese in their PN will maintain whole blood manganese concentrations above the&#xD;
      lower limit of normal.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 11, 2020</start_date>
  <completion_date type="Actual">July 22, 2021</completion_date>
  <primary_completion_date type="Actual">July 22, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants randomized to standard trace element dose in parenteral nutrition vs. omission of manganese.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Whole Blood Manganese</measure>
    <time_frame>Baseline</time_frame>
    <description>concentration of manganese in blood</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Whole Blood Manganese</measure>
    <time_frame>2 weeks of age</time_frame>
    <description>concentration of manganese in blood</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Whole Blood Manganese</measure>
    <time_frame>8 weeks of age</time_frame>
    <description>concentration of manganese in blood</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Infant, Newborn, Disease</condition>
  <arm_group>
    <arm_group_label>Standard neonatal trace elements</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Parenteral nutrition containing 5 mCg/kg/day manganese from &quot;Multitrace-4 Neonatal.&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manganese-free neonatal trace elements</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Parenteral nutrition containing the same trace element doses as &quot;Multitrace-4 Neonatal&quot; minus manganese.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manganese omission</intervention_name>
    <description>Participants randomized to the experimental intervention arm will not receive added manganese in their parenteral nutrition.</description>
    <arm_group_label>Manganese-free neonatal trace elements</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>5 mCg/kg/day manganese from &quot;Multitrace-4 Neonatal.&quot;</intervention_name>
    <description>5 mCg/kg/day manganese from &quot;Multitrace-4 Neonatal.&quot;</description>
    <arm_group_label>Standard neonatal trace elements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inborn admissions to the SHARP Mary Birch Hospital for Women and Newborns neonatal&#xD;
             intensive care unit.&#xD;
&#xD;
          -  Less than or equal to 32+6 weeks gestational age.&#xD;
&#xD;
          -  Initiated on parenteral nutrition as decided by their attending neonatologist.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Continuous exposure to routine care PN containing standard trace element for â‰¥ 4&#xD;
             hours.&#xD;
&#xD;
          -  Congenital liver disease.&#xD;
&#xD;
          -  Moribund status or imminent death.&#xD;
&#xD;
          -  Any condition that in the judgment of the investigator or attending physician provider&#xD;
             precludes participation because it could affect subject safety.&#xD;
&#xD;
          -  Lack or refusal of informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Day</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason B Sauberan, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sharp HealthCare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sharp Mary Birch Hospital for Women and Newborns</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2020</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sharp HealthCare</investigator_affiliation>
    <investigator_full_name>Jason Sauberan, PharmD</investigator_full_name>
    <investigator_title>Clinical Research Pharmacist</investigator_title>
  </responsible_party>
  <keyword>manganese, parenteral nutrition, neonate, preterm, safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Manganese</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial, after deidentification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Immediately after publication</ipd_time_frame>
    <ipd_access_criteria>Anyone</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

